Surgery Partners SGRY
Valuation
Multiples measured against the stock's own five-year history
Around its usual level · 54th percentile, 5-year average 68.8x
Above its usual level · 68th percentile, 5-year average 2.2x
#3196 of 5330 stocks by PB (1 = cheapest)
Around its usual level · 42nd percentile, 5-year average 1.2x
#1720 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 2.12 | – | 2.16 | 68% (pricier than usual) | #3196 of 5330 (1 = cheapest) |
| PE | -40.22 | 391.92 | 68.79 | 54% (pricier than usual) | – |
| PS | 1.05 | 1.26 | 1.21 | 42% (cheaper than usual) | #1720 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on SGRY.
Sign in to join the discussion.